drug

brensocatib

1 story · latest Aug 6, 2026

Status: FDA approved Aug 2025 · NDA217673
Brand: Brinsupri
Code: INS1007
Trials: 1 registered trial in coverage

Relationships

Developed by Insmed Incorporated

Timeline

Insmed raises BRINSUPRI guidance and combined peak sales estimate to over $14 billion

Aug 6Quarterly updatebrensocatib Insmed Incorporated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.